SCHEMBL8680807

SCHEMBL8680807

CCCCCCCCc1cc(Nc2ccccc2)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH3 Q9ULD8 1/20 0.42
TLR8 Q9NR97 3/20 0.41
MAPT P10636 7/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
KDM4E B2RXH2 2/20 0.41
GAA P10253 2/20 0.41
LMNA P02545 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
GFER P55789 1/20 0.41
ALDH1A1 P00352 7/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPK1 P28482 2/20 0.41
CYP3A4 P08684 3/20 0.41
HTT P42858 2/20 0.41
ALOX12 P18054 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1650229 1.00 KCNH3 (0.42) KCNH3TLR8MAPTMEN1KMT2A
SCHEMBL6535929 0.94 MAPT (0.43) KCNH3TLR8MAPTMEN1KMT2A
SCHEMBL30392107 0.94 MAPT (0.43) KCNH3TLR8MAPTMEN1KMT2A
SCHEMBL536379 0.88 MAPT (0.46) MAPTMEN1KMT2AKDM4EGAA
SCHEMBL21278352 0.85 KCNH3 (0.44) KCNH3MAPTMEN1KMT2AGAA
N,N'-Diphenyl-P-Phenylenediamine SCHEMBL1415255 0.81 MAPT (0.48) KCNH3TLR8MAPTMEN1KMT2A
SCHEMBL2904304 0.81 ALDH1A1 (0.42) MAPTMEN1KMT2AKDM4EGAA
SCHEMBL3796679 0.81 MAPT (0.48) MAPTMEN1KMT2AKDM4EGAA
SCHEMBL10763021 0.80 PPARA (0.46) KCNH3MEN1KMT2APPARAPTGS2
SCHEMBL28175584 0.80 TLR8 (0.40) TLR8MAPTMEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2759341-B1 METHOD FOR PREPARING P-PHENYLENEDIAMINE ANTIOXIDANT USING A SULFUR-CONTAINING PALLADIUM/CARBON CATALYST SENNICS CO LTD (CN) 2020-03-11 EP disclosed
US-9248443-B2 Sulfur-containing palladium-carbon catalyst and method for preparing and using the same JIANGSU SINORGCHEM TECHNOLOGY CO., LTD. (CN) 2016-02-02 US disclosed
EP-2759341-A1 SULFUR-CONTAINING PALLADIUM/CARBON CATALYST, PREPARATION METHOD THEREFOR, AND METHOD FOR PREPARING P-PHENYLENEDIAMINE ANTIOXIDANT Jiangsu Sinorgchem Technology Co., Ltd. (CN) 2014-07-30 EP disclosed
US-20130079559-A1 SULFUR-CONTAINING PALLADIUM-CARBON CATALYST AND METHOD FOR PREPARING AND USING THE SAME JIANGSU SINORGCHEM TECHNOLOGY CO., LTD. (CN) 2013-03-28 US disclosed
WO-1998055544-A1 CURABLE COMPOSITION HAVING A HIGH AMOUNT OF ANTIOZONANT AND AN ARTICLE MADE THEREFROM LORD CORPORATION (US) 1998-12-10 WO disclosed
US-4487759-A PHEROMONES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1984-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079559-A1 SULFUR-CONTAINING PALLADIUM-CARBON CATALYST AND METHOD FOR PREPARING AND USING THE SAME SOD1, SRM, SOD3 KCNH3 3927/4885TLR8 3876/4885MAPT 2626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.